Literature DB >> 1971767

Chronic benzodiazepine dependence. A comparative study of abrupt withdrawal under propranolol cover versus gradual withdrawal.

T Cantopher1, S Olivieri, N Cleave, J G Edwards.   

Abstract

Thirty-one patients dependent on benzodiazepines were randomly assigned to either slow withdrawal (SW) or abrupt withdrawal under propranolol cover (PW). Of 16 patients in the SW group, 11 successfully withdrew from their drugs, while only 4 out of 15 in the PW group did so. Patients in the SW group had only mild withdrawal symptoms, while those in the PW group suffered more severe symptoms, which lasted around four weeks. In all, 81% of the whole group suffered withdrawal symptoms of some kind. Patients in both groups were significantly less anxious at the end of the study than at baseline. Younger subjects and those who were more severely anxious at the start of the trial had more difficulty in withdrawing than older and less anxious patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1971767     DOI: 10.1192/bjp.156.3.406

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  12 in total

1.  Treatment of benzodiazepine withdrawal symptoms with carbamazepine.

Authors:  D Garcia-Borreguero; T Bronisch; S Apelt; A Yassouridis; H M Emrich
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

Review 2.  Metabolic diversity as a reason for unsuccessful detoxification from benzodiazepines: the rationale for serum BZD concentration monitoring.

Authors:  Anna Basińska-Szafrańska
Journal:  Eur J Clin Pharmacol       Date:  2021-01-03       Impact factor: 2.953

3.  Medicare part D's exclusion of benzodiazepines and fracture risk in nursing homes.

Authors:  Becky A Briesacher; Stephen B Soumerai; Terry S Field; Hassan Fouayzi; Jerry H Gurwitz
Journal:  Arch Intern Med       Date:  2010-04-26

4.  Challenges of a mechanistic feedback model describing nicotinic acid-induced changes in non-esterified fatty acids in rats.

Authors:  Christine Ahlström; Lambertus A Peletier; Johan Gabrielsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-07-04       Impact factor: 2.745

5.  Pilot trial of gabapentin for the treatment of benzodiazepine abuse or dependence in methadone maintenance patients.

Authors:  John J Mariani; Robert J Malcolm; Agnieszka K Mamczur; Jean C Choi; Ronald Brady; Edward Nunes; Frances R Levin
Journal:  Am J Drug Alcohol Abuse       Date:  2016-03-10       Impact factor: 3.829

Review 6.  Current benzodiazepine issues.

Authors:  J H Woods; G Winger
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

Review 7.  Withdrawing benzodiazepines in primary care.

Authors:  Malcolm Lader; Andre Tylee; John Donoghue
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

8.  Diazepam filled hard capsules intended for detoxification of patients addicted to benzodiazepines and Z-drugs.

Authors:  Aleš Franc; Kateřina Kubová; Jan Elbl; Jan Muselík; David Vetchý; Jan Šaloun; Radka Opatřilová
Journal:  Eur J Hosp Pharm       Date:  2017-07-24

Review 9.  Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review.

Authors:  André S Pollmann; Andrea L Murphy; Joel C Bergman; David M Gardner
Journal:  BMC Pharmacol Toxicol       Date:  2015-07-04       Impact factor: 2.483

Review 10.  Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users.

Authors:  Lone Baandrup; Bjørn H Ebdrup; Jesper Ø Rasmussen; Jane Lindschou; Christian Gluud; Birte Y Glenthøj
Journal:  Cochrane Database Syst Rev       Date:  2018-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.